Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Kathryn Partlow

Dr. Kathryn Partlow

Scientific Review Officer



Biography

Division:
Division of Neuroscience, Development and Aging – DNDA
Review Branch:
Aging and Neurodegeneration – AN
Study Section:
Small Business: Therapeutic Development for Alzheimer’s Disease and Related Dementias (ADRD) and Neurodegenerative Disorders – AN (11)

Dr. Kathy Partlow received her Ph.D. in molecular cell biology from Washington University, St. Louis. She conducted her graduate and postdoctoral work in laboratories that specialized in imaging (e.g., ultrasound and MRI) and organic chemistry, respectively. Dr. Partlow’s research experience has involved the development and characterization of novel drugs identified from high-throughput screens, as well as applications for improving delivery and therapeutic outcomes using nanoparticle carriers. Before joining CSR, she held an administrative role in academia where she promoted and supported interdisciplinary research, mainly through managing internal seed funding programs and helping large interdisciplinary teams compete for center-scale funding opportunities.

 

Last updated: 08/21/2025 05:05